AG真人官方

STOCK TITAN

NewGen Filed 2024 Annual Report on Form 20-F

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

NewGen IVF Group (NASDAQ: NIVF), an Asian fertility services provider, has filed its 2024 annual report on Form 20-F with the SEC on April 22, 2025. The company reported $2.48 million in cash and a $1 million cash deposit with a trading platform, which exceeds their current market capitalization of $1.48 million.

The company has improved its financial position by settling outstanding promissory notes and converting mandatory additional notes to equity. NewGen maintains access to a $100 million equity line of credit facility, of which $7.1 million has been utilized.

NewGen IVF Group (NASDAQ: NIVF), un fornitore asiatico di servizi per la fertilit脿, ha presentato il suo rapporto annuale 2024 sul modulo 20-F alla SEC il 22 aprile 2025. La societ脿 ha dichiarato di avere 2,48 milioni di dollari in contanti e un deposito in contanti di 1 milione di dollari presso una piattaforma di trading, superando cos矛 la sua attuale capitalizzazione di mercato di 1,48 milioni di dollari.

La societ脿 ha migliorato la propria posizione finanziaria estinguendo cambiali in sospeso e convertendo obbligazioni aggiuntive obbligatorie in capitale azionario. NewGen mantiene l'accesso a una linea di credito azionaria da 100 milioni di dollari, di cui sono stati utilizzati 7,1 milioni di dollari.

NewGen IVF Group (NASDAQ: NIVF), un proveedor asi谩tico de servicios de fertilidad, present贸 su informe anual 2024 en el formulario 20-F ante la SEC el 22 de abril de 2025. La empresa report贸 2,48 millones de d贸lares en efectivo y un dep贸sito en efectivo de 1 mill贸n de d贸lares en una plataforma de trading, superando su capitalizaci贸n de mercado actual de 1,48 millones de d贸lares.

La compa帽铆a mejor贸 su posici贸n financiera al saldar pagar茅s pendientes y convertir notas adicionales obligatorias en capital. NewGen mantiene acceso a una l铆nea de cr茅dito de capital por 100 millones de d贸lares, de los cuales se han utilizado 7,1 millones.

NewGen IVF Group (NASDAQ: NIVF), 鞎勳嫓鞎勳潣 靸濎嫕 靹滊箘鞀� 鞝滉车鞐呾泊臧 2025雲� 4鞗� 22鞚� SEC鞐� 2024雲� 鞐半 氤搓碃靹滌澑 Form 20-F毳� 鞝滌稖頄堨姷雼堧嫟. 須岇偓電� 248毵� 雼煬鞚� 順勱笀瓿� 瓯半灅 頂岆灚韽检棎 100毵� 雼煬鞚� 順勱笀 鞓堨箻旮�鞚� 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 順勳灛 鞁滉皜齑濎暋鞚� 148毵� 雼煬毳� 齑堦臣頃╇媹雼�.

須岇偓電� 氙戈舶鞝� 鞎届啀鞏挫潓鞚� 靸來櫂頃橁碃 頃勳垬 於旉皜 鞏挫潓鞚� 欤检嫕鞙茧 鞝勴櫂頃橃棳 鞛 靸來儨毳� 臧滌劆頄堨姷雼堧嫟. NewGen鞚 1鞏� 雼煬 攴滊鞚� 欤检嫕 鞁犾毄 頃滊弰鞐� 鞝戧芳頃� 靾� 鞛堨溂氅�, 攴� 欷� 710毵� 雼煬毳� 靷毄頄堨姷雼堧嫟.

NewGen IVF Group (NASDAQ : NIVF), un fournisseur asiatique de services en fertilit茅, a d茅pos茅 son rapport annuel 2024 sur le formulaire 20-F aupr猫s de la SEC le 22 avril 2025. La soci茅t茅 a d茅clar茅 disposer de 2,48 millions de dollars en liquidit茅s et d鈥檜n d茅p么t en esp猫ces d鈥檜n million de dollars sur une plateforme de trading, ce qui d茅passe sa capitalisation boursi猫re actuelle de 1,48 million de dollars.

L鈥檈ntreprise a am茅lior茅 sa situation financi猫re en r茅glant des billets 脿 ordre en souffrance et en convertissant des billets additionnels obligatoires en actions. NewGen conserve l鈥檃cc猫s 脿 une ligne de cr茅dit en actions de 100 millions de dollars, dont 7,1 millions ont 茅t茅 utilis茅s.

NewGen IVF Group (NASDAQ: NIVF), ein asiatischer Anbieter von Fruchtbarkeitsdienstleistungen, hat am 22. April 2025 seinen Jahresbericht 2024 im Formular 20-F bei der SEC eingereicht. Das Unternehmen meldete 2,48 Millionen US-Dollar in bar und eine 1 Million US-Dollar Bareinlage bei einer Handelsplattform, was die aktuelle Marktkapitalisierung von 1,48 Millionen US-Dollar 眉bersteigt.

Das Unternehmen hat seine Finanzlage verbessert, indem ausstehende Schuldscheine beglichen und verpflichtende Zusatzschuldscheine in Eigenkapital umgewandelt wurden. NewGen hat Zugang zu einer 100 Millionen US-Dollar Eigenkapitalkreditlinie, von der 7,1 Millionen US-Dollar in Anspruch genommen wurden.

Positive
  • Cash position ($3.48M total) exceeds current market cap ($1.48M)
  • Settlement of all outstanding promissory notes
  • Conversion of mandatory additional notes to equity
  • Access to $100M equity line of credit facility
Negative
  • Low market capitalization of $1.48M indicates weak market valuation
  • $7.1M already drawn from credit facility suggests reliance on external financing

BANGKOK, April 22, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (鈥淣ewGen鈥� or the 鈥淐ompany鈥�), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 22, 2025 Eastern Time. The annual report can be accessed on the Company鈥檚 investor relations website at .

Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, 鈥淲ith $2.48 million cash with bank and a cash deposit of $1 million with a trading platform company, significantly exceeding our current market capitalization of $1.48 million, we believe we are currently in a healthy liquidity situation. We've successfully strengthened our balance sheet by settling all outstanding promissory notes and converting several mandatory additional notes into equity. With access to our $100 million equity line of credit facility, of which approximately $7.1 million has been drawn to date, we remain well-positioned to pursue strategic opportunities in this dynamic market environment.鈥�

About NewGen
NewGen is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing comprehensive fertility services for its customers. NewGen鈥檚 management team collectively has over a decade of experience in the fertility industry. NewGen鈥檚 clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions, respectively. To learn more, visit . The information contained on, or accessible through, NewGen鈥檚 website is not incorporated by reference into this press release, and you should not consider it a part of this press release.

Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the 鈥渟afe harbor鈥� provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words 鈥渂elieve,鈥� 鈥減roject,鈥� 鈥渆xpect,鈥� 鈥渁nticipate,鈥� 鈥渆stimate,鈥� 鈥渋ntend,鈥� 鈥渟trategy,鈥� 鈥渇uture,鈥� 鈥渙pportunity,鈥� 鈥減lan,鈥� 鈥渕ay,鈥� 鈥渟hould,鈥� 鈥渨ill,鈥� 鈥渨ould,鈥� 鈥渨ill be,鈥� 鈥渨ill continue,鈥� 鈥渨ill likely result,鈥� and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company鈥檚 future commercial operations, investments, business strategy, and financial condition. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company鈥檚 ability to access financing or draw down on the equity line of credit, changes in market conditions, or other factors beyond the Company鈥檚 control. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company鈥檚 annual report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC鈥檚 website, www.sec.gov. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email:


FAQ

What is NewGen IVF Group's (NIVF) current cash position in 2024?

NewGen has $2.48 million in cash with bank and an additional $1 million cash deposit with a trading platform, totaling $3.48 million in liquid assets.

How much of NewGen's (NIVF) $100M credit facility has been used?

Approximately $7.1 million has been drawn from the $100 million equity line of credit facility.

What is NewGen IVF's (NIVF) current market capitalization?

NewGen's current market capitalization is $1.48 million.

What financial improvements has NewGen (NIVF) made in 2024?

NewGen has settled all outstanding promissory notes and converted several mandatory additional notes into equity.
NewGenIvf Group

NASDAQ:NIVF

NIVF Rankings

NIVF Latest News

NIVF Latest SEC Filings

NIVF Stock Data

4.67M
934.09k
2.24%
1.32%
10.86%
Medical Care Facilities
Healthcare
Hong Kong
Central